{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765961",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765961_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"aceclofenac\" outputclass=\"int-drug\">Aceclofenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Aceclofenac   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aceclofenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765962",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765962_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"aluminium hydroxide\" outputclass=\"int-drug\">Aluminium hydroxide</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"aluminium hydroxide\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/aluminium-hydroxide.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP287\">aluminium hydroxide</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Aluminium hydroxide   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  aluminium hydroxide  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aluminium hydroxide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765963",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765963_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"amikacin\" outputclass=\"int-drug\">Amikacin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Amikacin   increases   the risk of hypocalcaemia when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amikacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765964",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765964_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"aspirin\" outputclass=\"int-drug\">Aspirin</ph> <ph outputclass=\"int-substanceQualifier\">(high-dose)</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Aspirin   (high-dose)   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aspirin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765965",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765965_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"benzydamine\" outputclass=\"int-drug\">Benzydamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Benzydamine   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Benzydamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765966",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765966_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"bromfenac\" outputclass=\"int-drug\">Bromfenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Bromfenac   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bromfenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765967",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765967_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium acetate\" outputclass=\"int-drug\">calcium acetate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium acetate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-acetate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP104228\">calcium acetate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium acetate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  calcium acetate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium acetate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765968",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765968_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium carbonate\" outputclass=\"int-drug\">calcium carbonate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium carbonate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-carbonate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93602\">calcium carbonate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium carbonate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  calcium carbonate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium carbonate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765969",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765969_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium chloride\" outputclass=\"int-drug\">calcium chloride</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium chloride\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-chloride.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93603\">calcium chloride</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium chloride   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  calcium chloride  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium chloride</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765970",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765970_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium gluconate\" outputclass=\"int-drug\">calcium gluconate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium gluconate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-gluconate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93600\">calcium gluconate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium gluconate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  calcium gluconate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium gluconate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765971",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765971_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium lactate\" outputclass=\"int-drug\">calcium lactate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium lactate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-lactate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93601\">calcium lactate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium lactate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  calcium lactate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium lactate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765972",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765972_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium phosphate\" outputclass=\"int-drug\">calcium phosphate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium phosphate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-phosphate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP107980\">calcium phosphate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium phosphate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  calcium phosphate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium phosphate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765973",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765973_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"celecoxib\" outputclass=\"int-drug\">Celecoxib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Celecoxib   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Celecoxib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765974",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765974_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">Sodium clodronate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal bleeding when given with</ph> <ph otherprops=\"deferasirox\" outputclass=\"int-drug\">deferasirox</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Sodium clodronate   is predicted to   increase   the risk of gastrointestinal bleeding when given with   deferasirox .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Deferasirox</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765975",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765975_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dexibuprofen\" outputclass=\"int-drug\">Dexibuprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dexibuprofen   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexibuprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765976",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765976_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dexketoprofen\" outputclass=\"int-drug\">Dexketoprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dexketoprofen   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexketoprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765977",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765977_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"diclofenac\" outputclass=\"int-drug\">Diclofenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Diclofenac   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Diclofenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765978",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765978_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"etodolac\" outputclass=\"int-drug\">Etodolac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Etodolac   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Etodolac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765979",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765979_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"etoricoxib\" outputclass=\"int-drug\">Etoricoxib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Etoricoxib   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Etoricoxib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765980",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765980_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"felbinac\" outputclass=\"int-drug\">Felbinac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Felbinac   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Felbinac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765981",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765981_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ferric maltol\" outputclass=\"int-drug\">Ferric maltol</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"ferric maltol\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ferric-maltol.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP213389\">ferric maltol</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ferric maltol   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  ferric maltol  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ferric maltol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765982",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765982_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ferrous fumarate\" outputclass=\"int-drug\">Ferrous fumarate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"ferrous fumarate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ferrous-fumarate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP5839\">ferrous fumarate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ferrous fumarate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  ferrous fumarate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ferrous fumarate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765983",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765983_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ferrous gluconate\" outputclass=\"int-drug\">Ferrous gluconate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"ferrous gluconate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ferrous-gluconate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP5851\">ferrous gluconate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ferrous gluconate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  ferrous gluconate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ferrous gluconate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765984",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765984_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ferrous sulfate\" outputclass=\"int-drug\">Ferrous sulfate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"ferrous sulfate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ferrous-sulfate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP5823\">ferrous sulfate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ferrous sulfate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  ferrous sulfate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ferrous sulfate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765985",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765985_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"flurbiprofen\" outputclass=\"int-drug\">Flurbiprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Flurbiprofen   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flurbiprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765986",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765986_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"gentamicin\" outputclass=\"int-drug\">Gentamicin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Gentamicin   increases   the risk of hypocalcaemia when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gentamicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765987",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765987_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ibuprofen\" outputclass=\"int-drug\">Ibuprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ibuprofen   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ibuprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765988",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765988_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"indometacin\" outputclass=\"int-drug\">Indometacin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Indometacin   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Indometacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765989",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765989_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ketoprofen\" outputclass=\"int-drug\">Ketoprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ketoprofen   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketoprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765990",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765990_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ketorolac\" outputclass=\"int-drug\">Ketorolac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ketorolac   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketorolac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765991",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765991_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-drug\">magnesium</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"magnesium\" outputclass=\"int-drug\">magnesium</ph> (<ph otherprops=\"magnesium aspartate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-aspartate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14090\">magnesium aspartate</xref></ph>, <ph otherprops=\"magnesium glycerophosphate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-glycerophosphate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14092\">magnesium glycerophosphate</xref></ph>, <ph otherprops=\"magnesium hydroxide\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-hydroxide.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP104230\">magnesium hydroxide</xref></ph>, <ph otherprops=\"magnesium sulfate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-sulfate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6120\">magnesium sulfate</xref></ph>) for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  magnesium  ( magnesium aspartate ,  magnesium glycerophosphate ,  magnesium hydroxide ,  magnesium sulfate ) for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765992",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765992_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"magnesium carbonate\" outputclass=\"int-drug\">Magnesium carbonate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"magnesium carbonate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-carbonate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP298\">magnesium carbonate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Magnesium carbonate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  magnesium carbonate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium carbonate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765993",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765993_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"magnesium trisilicate\" outputclass=\"int-drug\">Magnesium trisilicate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"magnesium trisilicate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-trisilicate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP304\">magnesium trisilicate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Magnesium trisilicate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  magnesium trisilicate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium trisilicate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765994",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765994_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"mefenamic acid\" outputclass=\"int-drug\">Mefenamic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Mefenamic acid   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mefenamic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765995",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765995_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"meloxicam\" outputclass=\"int-drug\">Meloxicam</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Meloxicam   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Meloxicam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765996",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765996_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"nabumetone\" outputclass=\"int-drug\">Nabumetone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Nabumetone   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nabumetone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765997",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765997_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"naproxen\" outputclass=\"int-drug\">Naproxen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Naproxen   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Naproxen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765998",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765998_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"nepafenac\" outputclass=\"int-drug\">Nepafenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Nepafenac   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nepafenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765999",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280765999_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">Sodium clodronate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"parathyroid hormone\" outputclass=\"int-drug\">parathyroid hormone</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Sodium clodronate   is predicted to   decrease   the effects of   parathyroid hormone .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Parathyroid hormone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766000",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766000_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"parecoxib\" outputclass=\"int-drug\">Parecoxib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Parecoxib   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Parecoxib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766001",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766001_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"piroxicam\" outputclass=\"int-drug\">Piroxicam</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Piroxicam   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Piroxicam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766002",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766002_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"sodium feredetate\" outputclass=\"int-drug\">Sodium feredetate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"sodium feredetate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/sodium-feredetate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP5855\">sodium feredetate</xref></ph> for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Sodium feredetate   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  sodium feredetate  for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sodium feredetate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766003",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766003_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"streptomycin\" outputclass=\"int-drug\">Streptomycin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Streptomycin   increases   the risk of hypocalcaemia when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Streptomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766004",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766004_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"sulindac\" outputclass=\"int-drug\">Sulindac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Sulindac   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "44",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sulindac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766005",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766005_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"tenoxicam\" outputclass=\"int-drug\">Tenoxicam</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Tenoxicam   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "45",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tenoxicam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766006",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766006_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"tiaprofenic acid\" outputclass=\"int-drug\">Tiaprofenic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Tiaprofenic acid   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "46",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tiaprofenic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766007",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766007_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tobramycin\" outputclass=\"int-drug\">Tobramycin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tobramycin   increases   the risk of hypocalcaemia when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "47",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tobramycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766008",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766008_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"tolfenamic acid\" outputclass=\"int-drug\">Tolfenamic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of renal impairment when given with</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Tolfenamic acid   is predicted to   increase   the risk of renal impairment when given with   sodium clodronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "48",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tolfenamic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766009",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2#bnf_i1557280766009_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"zinc\" outputclass=\"int-drug\">zinc</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"zinc\" outputclass=\"int-drug\">zinc</ph> (<ph otherprops=\"zinc acetate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/zinc-acetate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6306\">zinc acetate</xref></ph>, <ph otherprops=\"zinc sulfate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/zinc-sulfate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6172\">zinc sulfate</xref></ph>) for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   zinc   decreases   the absorption of   oral   sodium clodronate .  Manufacturer advises avoid  zinc  ( zinc acetate ,  zinc sulfate ) for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "49",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Zinc</title>"
					}
				}
			],
			"hasSearchLabel": " Sodium clodronate  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/sodium-clodronate-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Sodium clodronate </title>"
			},
			"rdfs:label": "sodium clodronate"
		}
	]
}